Today a plethora of inter-company alliances exists. Firms have networked value chains, disclosing consequently their strategy, which assets are internalized or externalized, and their ability to cope with fast change. The picture of all interfirm alliances in high tech sectors is that of an...

Markets for technology can promote innovation by allowing for division of labor in research and development. Some firms may specialize in the discovery of ideas, while others have a comparative advantage in later stages of development and marketing. However, these gains depend on the timing of...

Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...

We analyze the diffusion and integration of external knowledge by distinguishing between the depth and breadth of technological knowledge in combination with the type of partner and channel of exchange. Using a latent variable structural equation model with a sample of 202 US biotechnology firms...

Why do firms outsource research and development (R&D) for some products while conducting R&D in-house for similar ones? An innovating firm risks cannibalizing its existing products. The more profitable these products, the more the firm wants to limit cannibalization. We apply this logic to the...

This paper quantifies the relationship between market size and innovation in the pharmaceutical industry using improved, and newer, methods and data. We find positive significant elasticities of innovation to expected market size with a point estimate under our preferred specification of 0.23....

This paper quantifies the relationship between market size and innovation in the pharmaceutical industry using improved, and newer, methods and data. We find positive significant elasticities of innovation to expected market size with a point estimate under our preferred specification of 0.23....

We analyse research collaboration in the Italian biotechnological sector using bibliometric data. We build a database of all scientific publications of Italian biotechnology firms over the period 1990 to may 2006 and we provide evidence on the institutional and geographical nature of research...

We analyse research collaboration in the Italian biotechnological sector using bibliometric data. We build a database of all scientific publications of Italian biotechnology firms over the period 1990 to may 2006 and we provide evidence on the institutional and geographical nature of research...

Innovation is becoming a fundamental tool of competitiveness of firms and economies. It is especially relevant in research intensive branches. Chemical industry belongs to one of the most innovative branches in Hungary. As innovation requires significant financial and knowledge resources company...